Published in Medical Letter on the CDC and FDA, May 27th, 2007
"We are extremely pleased to receive these contracts after the extensive due diligence and peer review process...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.